mPEG-PLGA-NH2, MW x 2K, n 5K provides a biodegradable amphiphilic block copolymer with terminal amine functionality for bioconjugation and nanoparticle research and specifically combines a 2 kDa methoxy polyethylene glycol (mPEG) block with a 5 kDa poly(lactic-co-glycolic acid) (PLGA) segment. Its terminal primary amine enables covalent modification, while the PLGA-rich structure supports drug encapsulation and controlled-release formulation studies.
Key Features and Benefits
- 2 kDa mPEG Block: Provides a hydrophilic polymer segment that contributes to nanoparticle surface hydration, aqueous dispersion, and colloidal stability.
- 5 kDa PLGA Block: Introduces a biodegradable hydrophobic polyester segment for polymer self-assembly, drug encapsulation, and controlled-release research.
- Terminal Primary Amine: Provides a reactive amino group for conjugation with compatible NHS esters, activated carboxyl groups, and other amine-reactive compounds.
- Amphiphilic Structure: Combines hydrophilic mPEG and hydrophobic PLGA segments to support polymer self-assembly under suitable formulation conditions.
- Biodegradable PLGA Segment: Contains hydrolytically degradable ester bonds that support investigations of polymer degradation, matrix erosion, and drug release behavior.
- PLGA-Rich Composition: Features a nominal 2:5 mPEG-to-PLGA molecular weight ratio, providing approximately 28.6% mPEG by combined block mass.
- Bioconjugation Compatibility: Supports amide bond formation and other amine-selective reactions for attaching compatible functional molecules to the polymer.
- Controlled-Release Potential: Provides a biodegradable PLGA segment for investigating drug diffusion, polymer hydrolysis, and sustained-release behavior.
- Chemical Modification Versatility: Enables attachment of fluorescent probes, functional linkers, and other compatible molecules through terminal amine chemistry.
Applications
- Amine-Based Bioconjugation: Enables covalent attachment of NHS ester-functionalized molecules and activated carboxyl compounds for polymer modification and conjugate development.
- Functionalized Nanoparticle Development: Supports preparation of biodegradable polymeric nanoparticles containing hydrophilic mPEG chains, PLGA domains, and reactive amine functionality.
- Targeted Drug Delivery Research: Enables attachment of compatible targeting ligands through amine-reactive linkers for investigating nanoparticle targeting strategies.
- Polymeric Micelle Research: Supports investigations of amphiphilic polymer self-assembly, micelle formation, and aggregation under suitable aqueous conditions.
- Fluorescent Polymer Labeling: Enables conjugation with amine-reactive fluorescent dyes for imaging, particle tracking, and analytical research.
- Hydrophobic Drug Encapsulation: Supports evaluation of compatible, poorly water-soluble compounds within biodegradable PLGA-containing polymer formulations.
- Controlled Drug Release: Facilitates investigations of drug diffusion, PLGA degradation, and matrix erosion in biodegradable delivery systems.
- Nanoparticle Surface Engineering: Enables chemical modification of polymer surfaces to investigate ligand presentation, hydration, protein interactions, and colloidal stability.
- Biodegradable Biomaterials: Provides an amine-functionalized polymer building block for developing experimental biodegradable materials and chemically modified delivery systems.
Storage and Handling
- Storage: Store at −20°C in a dry, tightly sealed container, protected from moisture and excessive heat. Follow product-specific storage instructions when available. Minimize humidity exposure to reduce premature PLGA hydrolysis.
- Handling: Handle using clean, dry equipment and dissolve in a compatible solvent, such as DMF, DMSO, acetone, or dichloromethane. Confirm solubility before selecting the formulation method.
- Prepare polymeric nanoparticles through nanoprecipitation, solvent exchange, or emulsification, depending on the desired formulation characteristics. The nominal 2:5 mPEG-to-PLGA ratio provides approximately 28.6% mPEG by combined block mass. This PLGA-rich composition may influence polymer self-assembly, particle size, surface hydration, and hydrophobic drug loading.
- Use the terminal primary amine for conjugation with NHS esters, activated carboxyl groups, or other compatible amine-reactive molecules. Select reaction conditions that preserve PLGA integrity and minimize unwanted hydrolysis. Control pH, reaction time, and reagent concentrations to support efficient conjugation.
- Evaluate amine functionality, conjugation efficiency, polymer integrity, particle size, drug loading, and formulation stability using appropriate analytical techniques. Remove residual coupling reagents and reaction byproducts when required by downstream applications. The PLGA-rich composition may favor hydrophobic domain formation but can affect aqueous dispersion. Avoid prolonged exposure to moisture, strong acids, and alkaline conditions. Confirm the PLGA lactide-to-glycolide ratio, terminal amine functionality, and polymer specifications before use.
mPEG-PLGA-NH2, MW x 2K, n 5K combines hydrophilic mPEG, biodegradable PLGA, and terminal primary amine functionality and specifically supports amine-based bioconjugation, functionalized nanoparticle development, hydrophobic drug encapsulation, and biodegradable drug delivery research.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
